NEWS and OPINIONS
Virtual Discussion Advancements Toward a Diabetes Cure
JUST IN! Major breakthrough for Type 1 diabetes that will provide an endless source of stem cell derived #isletcells for transplantation! When fully developed and deployed, there will be no longer be a need for organ transplants. Renowned researcher, first author of...
European first as County Durham stroke patient, 28, takes part in stem cell treatment trial
By Helen Ford - Health Correspondent, ITV News Tyne Tees A young patient from County Durham is the first in Europe to take part in a new trial to discover whether stem cell treatment can improve recovery from strokes. Harrison Kingsley, 28, suffered a serious stroke...
Judge tosses FDA lawsuit targeting a clinic offering unproven stem cell treatments
By Michael Hiltzik | Business Columnist | Los Angeles Times A federal judge in Riverside declared a California stem cell treatment firm to be exempt from Food and Drug Administration regulations, opening the door to the further proliferation of clinics offering...
A breakthrough for fast, efficient production of human immune cells
by University of British Columbia A University of British Columbia research team has developed a new, fast, efficient process for producing cancer-fighting immune cells in the lab. The discovery could help transform the field of immune cell therapy from an expensive,...
Common Viruses May Be Triggering the Onset of Alzheimer’s Disease
Shingles infection may activate dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated proteins in the brain by Mike Silver - TuftsNow Alzheimer’s disease can begin almost imperceptibly, often masquerading in the early...
After last year’s public rejection, BrainStorm to give ALS cell therapy another shot
by Tyler Patchen and Kyle LaHucik - EndpointsNews Above image caption: Chaim Lebovits, BrainStorm CEO After a rare public rejection from the FDA last year, BrainStorm Cell Therapeutics is headed back to the regulator with what it claims is a “correction” to Phase III...
A research partnership brings gene editing promise to eye disease
by Brian Mattmiller In order to tap the tremendous potential of CRISPR gene editing technology for reversing human disease, Wisconsin scientists are working with a star pupil. The human eye — though one of the body’s most complex and intricate structures — happens to...
Could Stem-Cell Based Therapy Treat Type-1 Diabetes? A New Study Demonstrates the Treatment’s Potential
By The Endocrine Society The findings suggest stem cell-based replacement therapy has the potential to manage blood sugar levels and may eventually replace the requirement for external insulin injections or dosing. Stem-cell therapy has promise in the treatment of...
Pioneering stem-cell trials in Japan report promising early results
The country has invested hundreds of millions of dollars into research on induced pluripotent stem cells to treat diseased organs. by: Smriti Mallapaty - Nature Some of the first trials to test whether reprogrammed stem cells can repair diseased organs have begun to...
Moderna sues Pfizer, BioNTech over COVID-19 vaccine
Moderna is suing Pfizer and BioNTech, alleging they copied technology that Moderna first developed years before the pandemic in producing the first COVID-19 vaccine approved in the U.S., the company announced Friday. Driving the news: Moderna is seeking unspecified...
‘Synthetic’ embryo with brain and beating heart grown from stem cells by Cambridge scientists
By Sarah Collins and Jacqueline Garget - University of Cambridge Researchers from the University of Cambridge have created model embryos from mouse stem cells that form a brain, a beating heart, and the foundations of all the other organs of the body – a new avenue...
Hydrogel that outperforms cartilage could be in human knees in 2023
By Michael Irving - New Atlas Joint pain is a common ailment of aging, thanks to cartilage’s tendency to wear out. Now, researchers at Duke University have developed a new hydrogel that’s stronger and more durable than the real thing, which could make for longer...